New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 17, 2012
12:16 EDTKO, JNJ, GS, FSLR, DNN, AMTG, ZNGAOn The Fly: Midday Wrap
Stocks on Wall Street were higher at midday, as the International Monetary Fund raised its view on U.S. and global growth prospects. Stock futures spurted higher during the pre-market trading session following the IMF’s increase in its growth projections. Also helping push the futures upward were positive earnings reports from some of the country’s largest corporations. The futures action led to a higher open for the broader market. The market pared its opening gains during the first 30 minutes of trading but then resumed it march higher and sat near its daily highs near noon... ECONOMIC EVENTS: Domestically, housing starts for the month of March decreased 5.8%, versus expectations of an increase of 1.0%. The annual run rate came in at 654,000 units, versus the consensus estimate of 750,000. The number of building permits issued, however, rose 4.5% to 747,000, versus expectations of a decrease of 0.7% to 710,000. Industrial production was reportedly flat in March, versus expectations for a 0.3% increase. Capacity utilization was in line with forecasts at at 78.6%. Also, the International Monetary Fund said it sees world output growing 3.5% in 2012, raising its projection for United States growth to 2.1%. The IMF said it sees growth in China slowing to 8.2% and real GDP in the euro area contracting in the first half of 2012 but then recovering... COMPANY NEWS: All but one Dow component was higher near noon, led by shares of Coca Cola (KO), which rose 2.7% following its better than expected earnings report. The only Dow decliner was Johnson & Johnson (JNJ), which reported adjusted earnings that beat expectations but revenues below the Street's forecast... Goldman Sachs's (GS) stock was nearly flat in spite of earnings and revenue that beat expectations and an increase in its quarterly dividend to 46c from 35c... MAJOR MOVERS: Among the notable gainers were First Solar (FSLR), up nearly 13%, after it announced plans to cut its global workforce by approximately 2,000 positions, or about 30%, in response to conditions in Europe, and Denison Mines (DNN), up almost 15%, after agreeing to sell its mining assets and operations located in the United States to Energy Fuels. Noteworthy losers included Apollo Residential Mortgage (AMTG), down 6%, after filing to sell 13.9M shares of its common stock, and Zynga (ZNGA), down over 3%, amid reports that its newly acquired Draw Something game has seen its daily active use fall off... INDICES: Near noon, the Dow was up 181.57, or 1.41%, to 13,102.98; the Nasdaq was up 50.58, or 1.69%, to 3,038.98; and the S&P 500 was up 19.24, or 1.40%, to 1,388.81.
News For KO;JNJ;GS;FSLR;DNN;AMTG;ZNGA From The Last 14 Days
Check below for free stories on KO;JNJ;GS;FSLR;DNN;AMTG;ZNGA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 27, 2014
16:05 EDTKOKeurig Green Mountain expands board, appoints José Octavio Reyes Lagunes
Subscribe for More Information
08:00 EDTGSSEC seen completing rules on MBS detail disclosures, WSJ says
The Securities and Exchange Commission is expected to complete rules requiring banks and other financial institutions to give investors greater detail about the quality of mortgages and other loans pooled into bonds known as asset-backed securities, reported The Wall Street Journal. Publicly traded big U.S banks include Bank of America (BAC), Citigroup (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC). Reference Link
August 26, 2014
09:51 EDTGSOn The Fly: Analyst Initiation Summary
Cray (CRAY) initiated with a Buy at Stifel... Enphase Energy (ENPH) initiated with a Buy at Needham... FCB Financial (FCB) initiated with a Buy at UBS... FCB Financial initiated with an Overweight at JPMorgan... Goldman Sachs (GS) initiated with a Buy at MKM Partners... HealthEquity (HQY) initiated with a Neutral at RW Bair... Mobileye (MBLY) initiated with a Buy at Deutsche Bank... Mobileye initiated with a Neutral at Goldman... Mobileye initiated with a Neutral at RW Baird... Mobileye initiated with an Overweight at Barclays... RAIT Financial (RAS) initiated with an Outperform at JMP Securities... SunEdison (SUNE) initiated with an Outperform at FBR Capital... Mobileye initiated with an Outperform at Raymond James... Transocean Partners (RIG) initiated with an Overweight at Morgan Stanley... GT Advanced (GTAT) coverage resumed with an Overweight at Piper Jaffray... LinkedIn (LNKD) initiated with an Overweight at First Analysis... CSC (CSC) initiated with a Sector Perform at RBC Capital... United Natural Foods (UNFI) initiated with an Overweight at Stephens.
07:52 EDTGSGoldman developing rival messaging system to Bloomberg, NY Post says
Goldman Sachs is wary of Bloomberg’s ability to analyze data collected via its ubiquitous terminals and the bank is developing a cross-bank messaging and market data program, called Symphony, as a result, according to The New York Post. Reference Link
06:20 EDTKOCoca-Cola to introduce mid-calorie soda in Mexico, WSJ reports
Subscribe for More Information
05:56 EDTGSGoldman Sachs initiated with a Buy at MKM Partners
Subscribe for More Information
August 25, 2014
09:35 EDTZNGAActive equity options trading on open
Subscribe for More Information
08:27 EDTJNJJanssen Affiliate Cilag acquires Covagen, terms not disclosed
Subscribe for More Information
07:32 EDTGSGoldman likely to name small new-partner class for 2014, WSJ reports
Subscribe for More Information
07:03 EDTJNJVIVUS acquires patents from Janssen Pharmaceuticals
VIVUS (VVUS) announced the acquisition of a group of patents from Janssen Pharmaceuticals (JNJ) covering uses of topiramate as monotherapy and in combination with other pharmaceutical agents to treat a variety of medical conditions. Janssen has agreed to dismiss the lawsuit it brought against VIVUS on August 22, 2014 in the U.S. District Court for the District of Delaware. VIVUS will pay a one-time upfront fee and a royalty to Janssen on Qsymia product sales for an assignment of these topiramate-related patents owned by Janssen. VIVUS has an option to buy out the royalty for a predetermined amount.
August 24, 2014
21:23 EDTGSLender group set to offer EDMC revised debt package, NY Post says
Subscribe for More Information
16:56 EDTGSGoldman likely to limit partner designations this fall, WSJ says
Subscribe for More Information
August 22, 2014
17:18 EDTGSGoldman Sachs announces agreements with FHFA to repurchase $3.15B in RMBS
Subscribe for More Information
13:41 EDTGSGoldman Sachs near $1.1B payment to settle FHFA claims, FT reports
Subscribe for More Information
06:42 EDTGSBlackstone in discussions to back China-based fund, Bloomberg says
Blackstone (BX) is in discussions to possibly back Hong Kong-based distressed fund, Arkkan Capital Management, which was founded by the former global leader of Goldman Sachs' (GS) special situations division Jason Brown, according to Bloomberg, citing two people with knowledge of the matter. Reference Link
August 21, 2014
06:43 EDTGSRegulators up bank warning efforts for poor risk assessment, Reuters says
Subscribe for More Information
05:42 EDTJNJIllumina announces strategic partnership with AstraZeneca, Sanofi, Janssen
Illumina (ILMN) announced it has formed collaborative partnerships with leading pharmaceutical companies to develop a universal next-generation sequencing, or NGS,-based oncology test system. The system will be used for clinical trials of targeted cancer therapies with a goal of developing and commercializing a multi-gene panel for therapeutic selection, resulting in a more comprehensive tool for precision medicine. Initial strategic partners include AstraZeneca (AZN), Janssen Biotech, a Johnson & Johnson (JNJ) company, and Sanofi (SNY). Illumina is working with the strategic partners to develop assays that detect and measure multiple variants simultaneously to support partners’ clinical trials, with the objectives of securing regulatory agency approvals and test commercialization. In parallel, Illumina is working with key thought leaders to set standards for NGS-based assays in routine clinical oncology practice, as well as to define regulatory frameworks to enable this new testing paradigm. Together, Illumina and its strategic partners aim to transition from single-analyte companion diagnostics to panel-based assays that select for “companion therapeutics.”
August 20, 2014
18:29 EDTGSBofA, JPMorgan weigh plans to raise salaries for junior bankers, Bloomberg says
Subscribe for More Information
11:37 EDTGSGoldman ups U.S. junior employees FY15 wages by 20%, Bloomberg says
Subscribe for More Information
10:32 EDTGSGoldman to up U.S. junior employees FY15 salaries by 20%, Bloomberg says
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use